Unknown

Dataset Information

0

Metabolism and biological activity of 25-fluorocholecalciferol, 24-dehydrocholecalciferol and 25-dehydrocholecalciferol in the rat.


ABSTRACT: Three side-chain analogues of cholecalciferol (vitamin D3) modified at C-25, namely 25-fluorocholecalciferol, 24-dehydrocholecalciferol and 25-dehydrocholecalciferol, conceived as potential inhibitors of the cholecalciferol 25-hydroxylase have been prepared and tested in the rat. These compounds markedly diminish conversion in vivo of cholecalciferol into 25-hydroxycholecalciferol, but are not antagonists of vitamin D action, because they themselves possess significant biological activity in vivo. Each compound is capable of stimulating the intestinal transport of calcium and the mobilization of calcium from bone in vitamin D-deficient rats. Biological responses equivalent to those generated by a physiological dose of cholecalciferol (0.05 microgram) are produced, however, only when the analogues are administered at high doses (5-50 microgram). The biological activity of 24-dehydrocholecalciferol and 25-dehydrocholecalciferol is shown to result from conversion, in vivo, to the natural hormone, 1 alpha,25-dihydroxycholecalciferol, whereas 25-fluorocholecalciferol is metabolically activated in the rat by hydroxylation to 1 alpha-hydroxy-25-fluorocholecalciferol. This latter conversion is the first reported example of the 1 alpha-hydroxylation of a vitamin D compound lacking the 25-hydroxy group.

SUBMITTER: Onisko BL 

PROVIDER: S-EPMC1161227 | biostudies-other | 1979 Jul

REPOSITORIES: biostudies-other

Similar Datasets

| S-EPMC1158628 | biostudies-other
| S-EPMC1218174 | biostudies-other
| S-EPMC6273273 | biostudies-literature
| S-EPMC521420 | biostudies-other
| S-EPMC9415778 | biostudies-literature
| S-EPMC1162742 | biostudies-other
| S-EPMC8903835 | biostudies-literature
| S-EPMC4053837 | biostudies-literature
| S-EPMC4777767 | biostudies-literature
| S-EPMC1153578 | biostudies-other